In conclusion, mTORC1/S6K/Akt/PLK1 signaling plays a critical role in maintaining the stability of TCTP protein in lung cancer cells, thereby conferring resistance to DNA-damaging anticancer drugs. This evidence concerns the gene PLK1 and lung cancer.